Home › Blood Cancers › Florida
Blood Cancers clinical trials in Florida
28 studies for Blood Cancers are looking for participants at sites in Florida.
Cities in Florida
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
- Moffitt Cancer Center, Tampa
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06697184A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- Memorial Healthcare System, Hollywood
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT04634552Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
- University of Miami Sylvester Comprehensive Cancer Center, Miami
Recruiting
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06910969Genomic Profiling in Cancer Patients
- Baptist Alliance MCI, Miami
RecruitingObservational study
All ages · All sexes · Updated Sep 24, 2026 · NCT01775072Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- SSAK Partners, Coral Springs
- Mayo Clinic - Jacksonville, Jacksonville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07648264Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
- Holy Cross Hospital, Michael & Dianne Bienes Comp Cancer Ctr ( Site 0022), Fort Lauderdale
- Mount Sinai Braman Comprehensive Cancer Center ( Site 0031), Miami Beach
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT03486873Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- Holy Cross Hospital, Fort Lauderdale
- Mayo Clinic in Florida, Jacksonville
RecruitingObservational study
All ages · All sexes · Updated Sep 17, 2026 · NCT04242095Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
- Mayo Clinic, Jacksonville
- Moffitt Cancer Center, Tampa
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Sep 3, 2026 · NCT04588922Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
- Schulze Family Foundation Cancer Clinic - Bonita Health Center, Bonita Springs
- Morton Plant Hospital, Clearwater
- and 11 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Sep 2, 2026 · NCT05334069Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
- University of Florida, Gainesville
RecruitingPhase 1/2Healthy volunteers welcome
Up to age 50 · All sexes · Updated Sep 1, 2026 · NCT05322850Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- University of Miami, Miami
- Moffitt Cancer Center & Research Institute, Tampa
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT07007312A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
- Tampa General Hospital, Tampa
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT06823167A Study of APG-3288 in Relapsed/Refractory Blood Cancers
- Mayo Clinic, Jacksonville
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT07424833The Florida ASCENT Study
- University of Florida, Gainesville
Recruiting
Ages 18 to 100 · All sexes · Updated Jul 23, 2026 · NCT07042243Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Moffitt Cancer Center, Tampa
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT07216443A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Florida Shands Medical Center, Gainesville
- Nemours Children's Hospital - Mayo Jacksonville, Jacksonville
- University of Miami (peds), Miami
- and 6 more
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545IVIG for Infection Prevention After CAR-T-Cell Therapy
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- Moffitt Cancer Center, Tampa
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05952804An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
- Mayo Clinic Jacksonville, Jacksonville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 11, 2026 · NCT06401356Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
- University of Florida, Gainesville
RecruitingPhase 2
6 Months – 39 Years · All sexes · Updated Jun 4, 2026 · NCT05800210Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- University of Miami, Miami
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT05663502Global Cardio Oncology Registry
- Cleveland Clinic Florida, Weston
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 12, 2026 · NCT05598879A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
- Nemours Children's Clinic-Jacksonville, Jacksonville
- Nicklaus Children's Hospital, Miami
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated May 5, 2026 · NCT05711667CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Mayo Clinic, Jacksonville
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 16, 2026 · NCT03328078A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- Mayo Clinic Jacksonville, Jacksonville
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Mar 13, 2026 · NCT05735184Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
- Mayo Clinic in Florida, Jacksonville
Recruiting
Ages 18 and older · All sexes · Updated Feb 23, 2026 · NCT02958462Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
- Sylvester Comprehensive Cancer Center, Miami
Recruiting
Ages 18 and older · All sexes · Updated Feb 20, 2026 · NCT05745285BMT-CARE: Psychosocial Intervention for Transplant Caregivers
- Moffitt Cancer Center, Tampa
Recruiting
Ages 18 and older · All sexes · Updated Oct 15, 2025 · NCT06472089Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- University of Miami, Miami
RecruitingPhase 1
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.